Results
|
521.
|
|
|
522.
|
|
|
523.
|
|
|
524.
|
|
|
525.
|
Efavirenz Capsule Sprinkle and Liquid Formulations With Didanosine and Emtricitabine in HIV-1-infected Infants and Children 3 Months to 6 Years of Age: Study AI266-922. [electronic resource] by
- Pavia-Ruz, Noris
- Rossouw, Magdel
- Sáez-Llorens, Xavier
- Bunupuradah, Torsak
- Taylor, Mathew
- Yang, Rong
- Sevinsky, Heather
- Krystal, Mark
- Lataillade, Max
- Seekins, Daniel
- Biguenet, Sophie
Producer: 20161017
In:
The Pediatric infectious disease journal vol. 34
Availability: No items available.
|
|
526.
|
|
|
527.
|
Simplification to a dual regimen with darunavir/ritonavir plus lamivudine or emtricitabine in virologically-suppressed HIV-infected patients. [electronic resource] by
- Fabbiani, Massimiliano
- Di Giambenedetto, Simona
- Poli, Andrea
- Borghetti, Alberto
- Castagna, Antonella
- Mondi, Annalisa
- Galizzi, Nadia
- Maillard, Myriam
- Gori, Andrea
- Cauda, Roberto
- De Luca, Andrea
- Gianotti, Nicola
Producer: 20190328
In:
The Journal of infection vol. 73
Availability: No items available.
|
|
528.
|
|
|
529.
|
12-Oxo-Phytodienoic Acid Acts as a Regulator of Maize Defense against Corn Leaf Aphid. [electronic resource] by
- Varsani, Suresh
- Grover, Sajjan
- Zhou, Shaoqun
- Koch, Kyle G
- Huang, Pei-Cheng
- Kolomiets, Michael V
- Williams, W Paul
- Heng-Moss, Tiffany
- Sarath, Gautam
- Luthe, Dawn S
- Jander, Georg
- Louis, Joe
Producer: 20190521
In:
Plant physiology vol. 179
Availability: No items available.
|
|
530.
|
|
|
531.
|
|
|
532.
|
|
|
533.
|
|
|
534.
|
|
|
535.
|
|
|
536.
|
|
|
537.
|
SAR studies of 6-(arylamino)-4,4-disubstituted-1-methyl-1,4-dihydro-benzo[d][1,3]oxazin-2-ones as progesterone receptor antagonists. [electronic resource] by
- Kern, Jeffrey C
- Terefenko, Eugene A
- Fensome, Andrew
- Unwallla, Ray
- Wrobel, Jay
- Zhu, Yuan
- Cohen, Jeffrey
- Winneker, Richard
- Zhang, Zhiming
- Zhang, Puwen
Producer: 20070424
In:
Bioorganic & medicinal chemistry letters vol. 17
Availability: No items available.
|
|
538.
|
|
|
539.
|
Cerebrospinal fluid exposure of efavirenz and its major metabolites when dosed at 400 mg and 600 mg once daily: a randomized controlled trial. [electronic resource] by
- Winston, Alan
- Amin, Janaki
- Clarke, Amanda
- Else, Laura
- Amara, Alieu
- Owen, Andrew
- Barber, Tristan
- Jessen, Heiko
- Avihingsanon, Anchalee
- Avinghsanon, Anchalee
- Chetchotisakd, Ploenchan
- Khoo, Saye
- Cooper, David A
- Emery, Sean
- Puls, Rebekah
Producer: 20160106
In:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 60
Availability: No items available.
|
|
540.
|
|